Last reviewed · How we verify
Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy
Approved treatments
- Tivdak · SEAGEN
Tisotumab vedotin is a tissue factor (TF)-directed antibody drug conjugate that targets and disrupts microtubule networks in cancer cells. - Tivdak · Seagen
Tivdak works by binding to a specific target on cancer cells, triggering an immune response to destroy the cancer.
Clinical guidelines
- FDA label — 2L
TIVDAK is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy patent landscape — cliff calendar, originator estates, attackable patents
- Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy treatment landscape brief
- Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy treatment updates RSS
Frequently asked questions about Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy
What drugs treat Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy?
Tracked treatments include Tivdak.
What is the treatment for Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy?
Standard treatment for Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy includes Tivdak. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy?
FDA label publishes guidelines for Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. 1 guideline references tracked.
Related
- Treatment landscape: Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy patent cliff · Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy CI report
- Treatment: Tivdak · SEAGEN
- Treatment: Tivdak · Seagen
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing